NattoPharma’s MenaQ7 vitamin K2 inhibits artery hardening in study

Related Articles

FormattedPicture

BUSINESS NEWS

New innovations in traditional ingredients were a key focus for many companies at last week’s Convention on Pharmaceutical Ingredients (CPHI) 2022 in Frankfurt,... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

PLT Health Solutions has received approval from the Non-GMO Project to sell its menatto brought by Japanese oils producer J-Oil Mills under this label. Menatto is a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Kappa Bioscience, a leading manufacturer of vitamin K2 under the brand name K2Vital, is introducing “the first” USDA organic-certified all-trans,... Read More

FormattedPicture

FOOD RESEARCH

On the occasion of World Menopause Day, the British Nutrition Foundation (BNF) is releasing findings revealing that the cost-of-living crisis has created barriers to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Ahead of SupplySide West Las Vegas, US (Oct 31 - Nov 4), NutritionInsight speaks to Thies Ripcke, director in business development for North America at Kappa... Read More

trans